This is read by an automated voice. Please report any issues or inconsistencies here. Raman used the debate to criticize the mayor’s Inside Safe program, which has moved thousands of people into ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company’s ...
Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial rumors of a sale surfaced. The deal is worth $1.075 billion, consisting of cash ...
New Delhi: The Delhi Police Special Cell on Saturday revealed that it had arrested four youths from three states for online radicalising and recruiting others with the aim to establish an Islamic ...
Routine QC/QA labs can conduct material assessments using single-range, basic Fourier transform-infrared (FT-IR) tool configurations. However, contemporary analytical labs face growing workloads from ...
This is read by an automated voice. Please report any issues or inconsistencies here. Mayor Karen Bass threw her support behind Councilmember Nithya Raman in 2024, helping Raman’s reelection bid in ...
Socialist Los Angeles mayoral candidate Nithya Raman stepped out of her stunning $1.9 million home Monday – as critics slammed her as a “master manipulator” who’s skilled at dodging questions from the ...
The probe into the car blast near Delhi's Red Fort on November 10 last year has exposed a much larger terror plan, with the sources saying the same module had plotted attacks on outlets of a global ...
AI-generated summary reviewed by our newsroom. Read our AI Policy. Plant will cease operations by end of 2026; layoffs continue into 2027. Company will phase out operations and transfer product lines ...
This special report covers the investigation into a car bomb explosion at Delhi's Red Fort, believed to be a suicide attack by Dr. Omar Mohammed.
Oct 28 (Reuters) - Medical equipment maker Thermo Fisher (TMO.N), opens new tab is nearing an all-cash takeover of U.S-based Clario in a deal that could value the clinical trial data management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results